Capricor Therapeutics | CAPR - Equity Capital And Reserves


Capricor Therapeutics reported $246.22M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Bioline Rx USD 20.83M 2.64M Mar/2026
Capricor Therapeutics USD 246.22M 32.48M Jun/2026
Cipla INR 344.32B 15.13B Mar/2026
Cytokinetics USD -173.49M 653.08M Jun/2026
Geron USD 218.61M 10.49M Jun/2026
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 151.23M 157.91M Mar/2026
J&J USD 84.97B 3.78B Jun/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Prothena USD 286.89M 25.72M Jun/2026
PTC Therapeutics USD -165.36M 15.1M Jun/2026
Sarepta Therapeutics USD 1.53B 22.7M Jun/2026